Soliton Selects RESONIC as Brand Name for FDA-Cleared Rapid Acoustic Pulse Device
The initial launch of the RESONIC brand for tattoo and cellulite indications is expected in Q2 of 2021.
The initial launch of the RESONIC brand for tattoo and cellulite indications is expected in Q2 of 2021.
While clinical AI dominates industry headlines, the most immediate, low-risk opportunities for plastic surgeons lie in front-office automation. Weave CEO Brett White discusses how implementing AI in your administrative workflows can streamline patient inquiries, capture more consultations, and reduce staff burnout without losing the personal touch.